Burrill Life Sciences Capital Fund III

Burrill Life Sciences Capital Fund III functions as a venture capital fund, investing in the global life sciences sector. It strategically allocates capital into a diverse portfolio, from early-stage innovations to public entities. The fund's approach supports developments in biotechnology, pharmaceuticals, and medical technology worldwide, targeting opportunities across various stages of company growth.

The fund was managed by Burrill & Co., a firm established by G. Steven Burrill. His understanding of the life sciences industry’s critical role and growth trajectory inspired dedicated investment vehicles. This insight aimed to accelerate advancements in healthcare and biological research, positioning the firm for specialized capital deployment to foster innovation within the sector.

Limited partners form the investor base, seeking to foster and participate in life sciences progress. The fund’s vision is to catalyze innovation, facilitate novel therapies and technologies, and support companies addressing global health challenges. It consistently empowers entrepreneurs to bring transformative solutions to market, driving future advancements in health.